If successful, the vaccine would be the first against Lyme disease in the United States since Lymerix, which was discontinued in 2002 because of poor sales.
Lyme disease vaccine in late-stage trials would be first in 20 years
If successful, the vaccine would be the first against Lyme disease in the United States since Lymerix, which was discontinued in 2002 because of poor sales.